Silence Therapeutics' market value is the price at which a share of Silence Therapeutics trades on a public exchange. It measures the collective expectations of Silence Therapeutics plc investors about its performance. Silence Therapeutics is trading at 1.60 as of the 17th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.6. With this module, you can estimate the performance of a buy and hold strategy of Silence Therapeutics plc and determine expected loss or profit from investing in Silence Therapeutics over a given investment horizon. Check out Silence Therapeutics Correlation, Silence Therapeutics Volatility and Silence Therapeutics Performance module to complement your research on Silence Therapeutics.
Please note, there is a significant difference between Silence Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silence Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Silence Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Silence Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Silence Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Silence Therapeutics.
0.00
11/19/2025
No Change 0.00
0.0
In 3 months and 1 day
02/17/2026
0.00
If you would invest 0.00 in Silence Therapeutics on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Silence Therapeutics plc or generate 0.0% return on investment in Silence Therapeutics over 90 days. Silence Therapeutics is related to or competes with Hansa Biopharma, Transgene, Genfit SA, Mayne Pharma, Oryzon Genomics, JW (Cayman), and Brii Biosciences. Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid th... More
Silence Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Silence Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Silence Therapeutics plc upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silence Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Silence Therapeutics' standard deviation. In reality, there are many statistical measures that can use Silence Therapeutics historical prices to predict the future Silence Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Silence Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Silence Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Silence Therapeutics plc owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0474, which indicates the firm had a 0.0474 % return per unit of risk over the last 3 months. We have found seventeen technical indicators for Silence Therapeutics plc, which you can use to evaluate the volatility of the company. Please review Silence Therapeutics' Coefficient Of Variation of 2211.38, risk adjusted performance of 0.0454, and Variance of 53.26 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Silence Therapeutics holds a performance score of 3. The entity has a beta of -0.66, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Silence Therapeutics are expected to decrease at a much lower rate. During the bear market, Silence Therapeutics is likely to outperform the market. Please check Silence Therapeutics' information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to make a quick decision on whether Silence Therapeutics' existing price patterns will revert.
Auto-correlation
0.48
Average predictability
Silence Therapeutics plc has average predictability. Overlapping area represents the amount of predictability between Silence Therapeutics time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Silence Therapeutics plc price movement. The serial correlation of 0.48 indicates that about 48.0% of current Silence Therapeutics price fluctuation can be explain by its past prices.
Additional Information and Resources on Investing in Silence Pink Sheet
When determining whether Silence Therapeutics plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Silence Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Silence Therapeutics Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Silence Therapeutics Plc Stock:
Silence Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Silence Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Silence Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...